WebNews
Please enter a web search for web results.
NewsWeb
Astra Zeneca's Camizestrant Faces FDA ODAC Review In ESR1-Mutated HR+/HER2" Breast Cancer - Onco Daily
1+ hour, 58+ min ago (707+ words) The FDA's Oncologic Drugs Advisory Committee review of camizestrant SERENA-6 places one of the most important questions in modern breast oncology directly in front of regulators: should a molecular signal of endocrine resistance be enough to change treatment before scans…...
Prostate Cancer Foundation Canada 2026 Grant-in-Aid Awards - Oncology News, Insights, Stories by Onco Daily
3+ hour, 57+ min ago (209+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...
Do D FY26 Prostate Cancer Research Programs - Oncology News, Insights, Stories by Onco Daily
4+ hour, 5+ min ago (216+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...
Prostate Cancer Research (UK Charity) Patient and Public Involvement (PPI) Seed Grant - Oncology News, Insights, Stories by Onco Daily
4+ hour, 18+ min ago (181+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...
Prostate Cancer Research (UK Charity) Collaboration Seed Grant - Oncology News, Insights, Stories by Onco Daily
4+ hour, 20+ min ago (193+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...
Acute Lymphoblastic Leukemia (ALL) in Adults vs Children: Why Such Differences in Survival - Onco Daily
7+ hour, 52+ min ago (1648+ words) This explains many of the classic manifestations of ALL: Mediastinal involvement, more common in T-lineage ALL, which may cause cough, chest discomfort, dyspnea, or symptoms of superior vena cava compression. Patients with mature B-cell ALL (Burkitt's disease) may present with…...
Strengthening Collaboration and Innovation in Healthcare at IUCC 2026 - Onco Daily
8+ hour, 36+ min ago (63+ words) Interdisciplinary Urology Care Consortium (IUCC) shared a post on Linked In: "We are proud to introduce our exhibitor, Algorithm. With a legacy dating back to 1961, Algorithm continues to advance healthcare across the MENA region through quality pharmaceutical solutions and a…...
Ruthresh Rao Subramanyan: Shaping the Future of Preventive Healthcare with AI in a Powerful Room - Onco Daily
8+ hour, 30+ min ago (214+ words) Ruthresh Rao Subramanyan, Assistant Medical Director at the National Cancer Society Malaysia, shared a post on Linked In: "Shaping the Future of Preventive Healthcare with AI in a powerful room Had an energising and forward-looking session at the Jeffrey Cheah…...
Immunotherapy in Oncology (20252026): FDA Approvals and NCCN Evidence - Onco Daily
11+ hour, 36+ min ago (975+ words) These developments are now being rapidly incorporated into clinical practice, with multiple recent FDA approvals and updates in National Comprehensive Cancer Network guidelines (20252026) redefining standards of care across several tumor types. In early-stage triple-negative breast cancer, the KEYNOTE-522 trial established…...
Amer Zeidan: Join Yale Experts for an In-Depth Multiple Myeloma Meeting - Onco Daily
12+ hour, 7+ min ago (115+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...